Seagen

Dec 12 (Reuters) - Pfizer (PFE.N) said on Tuesday it expects to close its $43 billion deal to buy cancer drugmaker Seagen (SGEN.O) later this week and plans to create a new …
Trends
Pfizer agreed to acquire cancer drug maker Seagen for $43 billion. Merck & Co. had previously tried to buy Seagen, which is worth more than $30 billion, but the …
Pfizer CEO Albert Bourla said the company will be able to deliver Seagen’s cancer therapy to the world “at a scale that has not been seen before” with its $43 billion …
Seagen is a biotechnology company that develops novel antibody-drug conjugates (ADCs) and other targeted cancer medicines. Learn about their pipeline, technologies, and …
Pfizer has agreed to acquire oncology-focused biotech Seagen for a total enterprise value of $43bn as the US pharmaceutical company refills its drugs pipeline …
Pfizer will pay $43 billion in cash to buy Seagen, a global leader in antibody-drug conjugate (ADC) technology for cancer treatment. The deal will enhance Pfizer's …
Ph.D. in Biochemistry with solid foundation in drug development industry (13+ years)…. · Experience: Seagen · Education: Project Management Professional (PMP)® Certification · Location ...
Pfizer completes its acquisition of Seagen, a leader in Antibody-Drug Conjugate (ADC) technology, for $43 billion. The deal expands Pfizer's Oncology …
Renewed Hope in Advanced Anal Cancer With ICI-Chemo Combo. Liam Davenport. September 16, 2024. 0. BARCELONA, Spain — Adding retifanlimab, an …
Welcome back. Highly motivated research scientist in clinical and pre-clinical PK/PD of small molecule…. · Experience: Seagen · Education: University of Houston · …
See more